Market Synopsis

Market Research Future (MRFR) asserts that the global urinalysis test market is slated to demonstrate a stellar CAGR during the forecast period (2017-2023). The increased demand for point of care testing devices is likely to favor the market growth. Urinalysis is referred to as a urine test which is performed to detect and manage disorders like liver disease, urinary tract infections, diabetes, and kidney disease. A cost-effective and non-invasive analysis method, urinalysis involves checking the content, appearance, and concentration of the urine. These kinds of tests are highly recommended during a routine examination, pregnancy checkup, and pre-surgery preparation in order to detect any disease condition.

Market Potential and Pitfalls

The UTI testing market is growing at breakneck speed due to the rising demand for point of care testing devices, developing technologies in the field of diagnostics, and increased prevalence of chronic diseases across the globe. The cost-effectiveness along with the augmenting demand for urine automated urine analyzers are acting as push factors for the growth of the market. As per the National Institute of Diabetes and Digestive and Kidney Diseases, the prevalence of chronic kidney disease among the general population is about 14%. The urinalysis market has undergone several technological advancements which are further anticipated to boost the market across the globe as such advancements have proved to improve the reliability and efficiency of the results. Moreover, urine analyzers are integrated with Electronic Health Records in order to link the results directly into the database of the patient. Siemens AG has collaborated with Relaymed in order to bring labs cloud-based connectivity for Clinitek Status POC instruments and the Siemens DCA Vantage analyzer. With the change in lifestyle and increasing incidences of chronic diseases, there is an increased demand for advanced and quick tests, which has further resulted in the growth of the market.

Competitive Dashboard

The prominent players operating in the urinalysis test market are Dahaner (U.S.), ARKRAY Inc. (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Sysmex Corporation (Japan), Siemens AG (U.S.), Bio-Rad Laboratories Inc.  (U.S.), and ACON Laboratories Inc. (U.S.).

Global Urinalysis Test Market: Segmental Analysis

The global urinalysis test market has been segmented on the basis of test type, product type, end user, and application.

By mode of product type, the global urinalysis test market has been segmented into consumables and instruments. Among these, the consumables are expected to hold a significant share in the global market owing to its extensive use in the disposables in urinalysis research and testing. Moreover, the advent of advanced reagents and use of disposables are likely to favor the growth of the segment.

By mode of test type, the global urinalysis test market has been segmented into biochemical urinalysis, macroscopic urinalysis, urinalysis analyzer and sediments/microscopic urinalysis. Among these, the biochemical urinalysis is likely to occupy a significant share owing to the rapidly increasing geriatric population coupled with the increased incidences of kidney diseases and urinary tract infections.

By mode of application, the global urinalysis test market has been segmented into disease diagnosis comprising diagnosis of diseases like liver disease, kidney disease, pregnancy tests, diabetes, and others.

By mode of end-users, the global urinalysis test market has been segmented into independent laboratories, hospitals, and physician practices.

Regional Insights

Geographically, the urinalysis test market span across regions namely, Europe, America, Asia Pacific, and the Middle East Africa.

Considering the global scenario, America is considered to occupy the largest market share due to the increased demand for automated urine analyzers, accelerating incidences of liver and kidney diseases, and technological advancements in this region. In the North American region, the U.S. is estimated to hold the major share due to the high concentration of market giants manufacturing consumables and urine analyzers.

Europe occupies the second position and is anticipated to expand at a steady pace. The growth is credited to the rising prevalence of chronic diseases such as diabetes. Moreover, the availability of cost-effective treatment coupled with the rising funding from the government for RD activities is further triggering the demand for urinalysis test in this region.

The Asia Pacific is presumed to grow at the fastest rate due to the augmenting incidences of chronic diseases such as kidney, diabetes, and others. Moreover, with the changing lifestyle and increasing demand for urine analyzers, the market is likely to boom in this region.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013,

United States of America